TELONasdaqPharmaceutical PreparationsFiscal year ends December 31
Telomir Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.04−0.01 (-0.95%)
Close on Oct 19, 2026
- Market cap
- $63.27M
- P/E (TTM)
- –
- Dividend yield
- –
Telomir Pharmaceuticals statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Telomir Pharmaceuticals | Industry median |
|---|---|---|
| Market Cap | $71.53M | $166.30M |
| Enterprise Value | $66.36M | $88.19M |
| PB Ratio | 14.21 | 2.03 |
| P/TBV Ratio | 14.21 | 2.29 |
Income (trailing twelve months)
| Measure | Telomir Pharmaceuticals | Industry median |
|---|---|---|
| Net Income | -$5.88M | -$22.46M |
| EPS (Diluted) | -$0.91 | -$0.83 |
Returns
| Measure | Telomir Pharmaceuticals | Industry median |
|---|---|---|
| Return on Equity (ROE) | -213.1% | -53.2% |
| Return on Assets (ROA) | -189.7% | -40.9% |
Balance sheet
| Measure | Telomir Pharmaceuticals | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $5.17M | $61.43M |
| Net Cash (Debt) | $5.17M | $15.35M |
| Net Cash Per Share | $0.08 | $0.66 |
| Equity (Book Value) | $5.03M | $49.09M |
| Book Value Per Share | $0.07 | $1.37 |
| Tangible Book Value | $5.03M | $23.52M |
| Working Capital | $5.03M | $76.81M |
Financial position
| Measure | Telomir Pharmaceuticals | Industry median |
|---|---|---|
| Current Ratio | 16.14 | 3.34 |
| Quick Ratio | 15.55 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Telomir Pharmaceuticals | Industry median |
|---|---|---|
| Operating Cash Flow | -$4.91M | -$12.35M |
Efficiency
| Measure | Telomir Pharmaceuticals | Industry median |
|---|---|---|
| Profits Per Employee | -$196 | -$703.34K |
| Employee Count | 30,000 | 74 |
Dividends and yields
| Measure | Telomir Pharmaceuticals | Industry median |
|---|---|---|
| Earnings Yield | -8.22% | -23.3% |
Shares
| Measure | Telomir Pharmaceuticals | Industry median |
|---|---|---|
| Shares Outstanding | 68,775,000 | 58,127,000 |
| Shares Change (YoY) | 35.3% | 10.9% |
| Shares Change (QoQ) | 100.0% | 0.54% |
| Float | 49,324,000 | 49,136,700 |
| Shares Held by Insiders | 28.3% | 11.6% |
| Shares Held by Institutions | 4.33% | 59.4% |
Scores
| Measure | Telomir Pharmaceuticals | Industry median |
|---|---|---|
| Altman Z-Score | 118.82 | -0.22 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from Telomir Pharmaceuticals's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.